Pub Date : 2012-05-01DOI: 10.1521/CAPN.2012.17.2.1
Sarah B. Johnson
{"title":"Treatment of Adolescent Alcohol Abuse and Dependence","authors":"Sarah B. Johnson","doi":"10.1521/CAPN.2012.17.2.1","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.2.1","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"17 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.2.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-05-01DOI: 10.1521/CAPN.2012.17.2.5
B. Keeshin, J. Strawn
Conclusion and Summary Multiple treatments exist for the treatment of alcohol use disorders in adolescents. Current literature and evidence focuses mainly on adult populations. Clinical trials investigating pharmacologic treatment of alcohol use disorders in children and adolescents are limited. When discussing treatment with an adolescent who suffers from a substance use disorder, it is important to discuss risks and benefits of pharmacotherapy and also explain to the patient and family that these medications have been primarily studied in adult populations. Family therapy may be particularly important when treating adolescents with substance use disorders and addressing comorbid psychiatric conditions also yields better outcomes. Sarah B. Johnson, M.D., M.Sc., University of Louisville Department of Psychiatry, 401 E. Chestnut St., Ste. 610, Louisville, KY 40202. E-mail: sarah. johnson@louisville.edu.
结论与总结青少年酒精使用障碍存在多种治疗方法。目前的文献和证据主要集中在成年人群。研究儿童和青少年酒精使用障碍药物治疗的临床试验是有限的。当与患有物质使用障碍的青少年讨论治疗时，重要的是要讨论药物治疗的风险和益处，并向患者和家属解释这些药物主要是在成人人群中研究的。当治疗青少年物质使用障碍和解决共病精神疾病时，家庭治疗可能特别重要，也会产生更好的结果。Sarah B. Johnson，医学博士，文学硕士，路易斯维尔大学精神病学系，401 E. Chestnut St.， St. 610，路易斯维尔，肯塔基州40202。电子邮件:莎拉。johnson@louisville.edu。
{"title":"Treatment of Children and Adolescents with Posttraumatic Stress Disorder (PTSD): A Review of Current Evidence","authors":"B. Keeshin, J. Strawn","doi":"10.1521/CAPN.2012.17.2.5","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.2.5","url":null,"abstract":"Conclusion and Summary Multiple treatments exist for the treatment of alcohol use disorders in adolescents. Current literature and evidence focuses mainly on adult populations. Clinical trials investigating pharmacologic treatment of alcohol use disorders in children and adolescents are limited. When discussing treatment with an adolescent who suffers from a substance use disorder, it is important to discuss risks and benefits of pharmacotherapy and also explain to the patient and family that these medications have been primarily studied in adult populations. Family therapy may be particularly important when treating adolescents with substance use disorders and addressing comorbid psychiatric conditions also yields better outcomes. Sarah B. Johnson, M.D., M.Sc., University of Louisville Department of Psychiatry, 401 E. Chestnut St., Ste. 610, Louisville, KY 40202. E-mail: sarah. johnson@louisville.edu.","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"17 1","pages":"5-10"},"PeriodicalIF":0.0,"publicationDate":"2012-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.2.5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67089592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-03-21DOI: 10.1521/CAPN.2012.17.1.5
G. Carlson, E. Youngstrom
The Problem Multiple informants in the psychiatric assessment of children with behavior and emotional problems are a blessing and a curse. They are a blessing because one is able presumably to ascertain a much more comprehensive picture of the child’s functioning. They are a curse because clinicians and researchers are forced to reconcile information that is often conflicting. Do discrepancies tell us something about the informant (the person interviewed/completing a rating scale), something about the child, or both (De Los Reyes & Kazdin, 2005)? Informants generally consist of the parent and/or child and/or child’s teacher. Concerns about the reliability of the child’s self-reported behavior and emotional symptoms have led mental health clinicians, psychiatric epidemiologists and geneticists to rely on assessments collected from parents and teachers to measure the issues in question. Numerous studies have documented low to moderate associations between parent and teacher reports of children’s psychological symptoms, with Pearson correlations varying from approximately 0.2 to 0.4 (Achenbach, McConaughy, & Howell, 1987). It appears that prevalence (e.g., Boyle et al., 1996), genetic influence (e.g., Thapar and Rice, 2006) and diagnosis (e.g., Carlson & Blader, 2011; Owens & Hoza, 2003) varies depending on the informant. Discrepancies between informants may occur for a variety of reasons.
{"title":"The Clinician Implications of Informant Variance, with Special Attention to Mania","authors":"G. Carlson, E. Youngstrom","doi":"10.1521/CAPN.2012.17.1.5","DOIUrl":"https://doi.org/10.1521/CAPN.2012.17.1.5","url":null,"abstract":"The Problem Multiple informants in the psychiatric assessment of children with behavior and emotional problems are a blessing and a curse. They are a blessing because one is able presumably to ascertain a much more comprehensive picture of the child’s functioning. They are a curse because clinicians and researchers are forced to reconcile information that is often conflicting. Do discrepancies tell us something about the informant (the person interviewed/completing a rating scale), something about the child, or both (De Los Reyes & Kazdin, 2005)? Informants generally consist of the parent and/or child and/or child’s teacher. Concerns about the reliability of the child’s self-reported behavior and emotional symptoms have led mental health clinicians, psychiatric epidemiologists and geneticists to rely on assessments collected from parents and teachers to measure the issues in question. Numerous studies have documented low to moderate associations between parent and teacher reports of children’s psychological symptoms, with Pearson correlations varying from approximately 0.2 to 0.4 (Achenbach, McConaughy, & Howell, 1987). It appears that prevalence (e.g., Boyle et al., 1996), genetic influence (e.g., Thapar and Rice, 2006) and diagnosis (e.g., Carlson & Blader, 2011; Owens & Hoza, 2003) varies depending on the informant. Discrepancies between informants may occur for a variety of reasons.","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2012-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2012.17.1.5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-12-01DOI: 10.1521/CAPN.2011.16.6.1
Jelle R. Lettinga, Cora H. Drent, P. Hoekstra, J. Buitelaar, J. Glennon
{"title":"Clinical Pharmacology of Conduct Disorder: A Critical Review","authors":"Jelle R. Lettinga, Cora H. Drent, P. Hoekstra, J. Buitelaar, J. Glennon","doi":"10.1521/CAPN.2011.16.6.1","DOIUrl":"https://doi.org/10.1521/CAPN.2011.16.6.1","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"16 1","pages":"1-10"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2011.16.6.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67089962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-12-01DOI: 10.1521/CAPN.2011.16.6.10
Cora H. Drent, Jelle R. Lettinga, J. Buitelaar, J. Glennon, P. Hoekstra
Sinzig, J., Dopfner, M., Lehmkuhl, G., Uebel, H., Schmeck, K., Poustka, F., et al. (2007). Long-acting methylphenidate has an effect on aggressive behavior in children with attentiondeficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17(4), 421-432. Snyder, R., Turgay, A., et al. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41(9), 1026-1036.
{"title":"Risperidone-Induced Adverse Reactions in Children and Adolescents: A Literature Overview","authors":"Cora H. Drent, Jelle R. Lettinga, J. Buitelaar, J. Glennon, P. Hoekstra","doi":"10.1521/CAPN.2011.16.6.10","DOIUrl":"https://doi.org/10.1521/CAPN.2011.16.6.10","url":null,"abstract":"Sinzig, J., Dopfner, M., Lehmkuhl, G., Uebel, H., Schmeck, K., Poustka, F., et al. (2007). Long-acting methylphenidate has an effect on aggressive behavior in children with attentiondeficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17(4), 421-432. Snyder, R., Turgay, A., et al. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41(9), 1026-1036.","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2011.16.6.10","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67090009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-10-05DOI: 10.1521/CAPN.2011.16.4.6
Matthew E. Hirschtritt, Denise Bedoya
Introduction In the previous two articles in this series on rating scales, we summarized common characteristics, factors to consider when choosing among measures, and descriptions of various general scales used for screening and assessing severity of domains such as anxiety, mood, and problems at home and in school as well as overall functioning. Here, we conclude with a description of symptom-specific scales for youths suffering from disorders commonly encountered among practitioners who prescribe psychotropic medications to children and adolescents for psychiatric conditions. These measures have been used in clinical trials for preand posttreatment assessment of disorder severity prior to and throughout the course of treatment. Clinicians may add selected scales to supplement unstructured interviews and assessments to help inform their treatment plan. Like the general measures, we have selected these scales among the many that are available based on their numerous citations in the literature, rigorous empirical evidence for their validity, reliability, and clinical experience.
{"title":"Symptom-Specific Rating Scales in Child and Adolescent Psychiatry Clinical Practice","authors":"Matthew E. Hirschtritt, Denise Bedoya","doi":"10.1521/CAPN.2011.16.4.6","DOIUrl":"https://doi.org/10.1521/CAPN.2011.16.4.6","url":null,"abstract":"Introduction In the previous two articles in this series on rating scales, we summarized common characteristics, factors to consider when choosing among measures, and descriptions of various general scales used for screening and assessing severity of domains such as anxiety, mood, and problems at home and in school as well as overall functioning. Here, we conclude with a description of symptom-specific scales for youths suffering from disorders commonly encountered among practitioners who prescribe psychotropic medications to children and adolescents for psychiatric conditions. These measures have been used in clinical trials for preand posttreatment assessment of disorder severity prior to and throughout the course of treatment. Clinicians may add selected scales to supplement unstructured interviews and assessments to help inform their treatment plan. Like the general measures, we have selected these scales among the many that are available based on their numerous citations in the literature, rigorous empirical evidence for their validity, reliability, and clinical experience.","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"94 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2011.16.4.6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67089898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2011-10-05DOI: 10.1521/CAPN.2011.16.4.1
Ruth Graupera-Frain, R. Lee
{"title":"Issues to Consider Regarding the Prescription of Selective Serotonin Reuptake Inhibitors to Pregnant Adolescents","authors":"Ruth Graupera-Frain, R. Lee","doi":"10.1521/CAPN.2011.16.4.1","DOIUrl":"https://doi.org/10.1521/CAPN.2011.16.4.1","url":null,"abstract":"","PeriodicalId":89750,"journal":{"name":"Child & adolescent psychopharmacology news","volume":"16 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2011-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1521/CAPN.2011.16.4.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67089841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：